|
2022
|
Invention
|
Trpa1 antagonist for the treatment of pain associated to diabetic neuropathic pain.
The present ... |
|
2019
|
Invention
|
Expression constructs and methods for expressing polypeptides in eukaryotic cells.
The invention... |
|
|
Invention
|
Antibody formulation.
A pharmaceutical formulation is described comprising a therapeutically eff... |
|
|
Invention
|
Anti-ox40 antagonistic antibodies and dosage for the treatment of ox40-mediated disorders. The pr... |
|
|
Invention
|
Combined bispecific antibody and immuno-oncology therapies. The present invention relates to comb... |
|
|
Invention
|
Anti-ox40 antagonistic antibodies for the treatment of autoimmune diseases. The present invention... |
|
|
Invention
|
Compounds as ror gamma modulators. b, n, m, p and q are as defined herein, which are active as mo... |
|
|
Invention
|
Methods of inactivating viral contaminants.
The present invention relates to a method for prepar... |
|
2018
|
Invention
|
Carbocyclic compounds as ror gamma modulators. b, n, m and p are as defined herein, which are act... |
|
|
Invention
|
Mpges-1 inhibitor for the treatment of osteoarthritis pain. The present invention relates to a mi... |
|
|
Invention
|
Methods of inactivating viral contaminants. The present invention relates to a method for prepari... |
|
|
Invention
|
Novel inhibitors of map4k1. The invention relates to novel inhibitors of MAP4K1 (HPK1) useful for... |
|
|
Invention
|
Substituted bicyclic heterocyclic compounds as nadph oxidase inhibitors.
The present application... |
|
|
Invention
|
Substituted bicyclic heterocyclic compounds as nadph oxidase inhibitors. The present application ... |
|
|
Invention
|
T cell redirecting bispecific antibodies for the treatment of egfr positive cancers. The present ... |
|
|
Invention
|
Substituted oxoazetidine analogues as ror gamma modulators. The present disclosure is directed to... |
|
2017
|
Invention
|
Substituted morpholine derivatives as ror gamma modulators. The present disclosure is directed to... |
|
|
Invention
|
Novel tnfr agonists and uses thereof.
The present invention relates to a new class of TNFR agoni... |
|
|
Invention
|
Novel tnfr agonists and uses thereof. The present invention relates to a new class of TNFR agonis... |
|
|
Invention
|
1,2,3-benzotriazole derivatives as ror gamma t modulators. The present disclosure is directed to ... |
|
|
Invention
|
Expression cassette.
The present invention relates to an expression cassette useful for the expr... |
|
|
Invention
|
Hetero-dimeric immunoglobulins.
The present invention relates to engineered hetero-dimeric immun... |
|
|
Invention
|
Antibodies that bind to tl1a and their uses.
The present invention relates to antibodies or frag... |
|
|
Invention
|
Pharmaceutical foam composition. The present invention relates to azelaic acid foam compositions ... |
|
|
Invention
|
Syringe device. The syringe device according to present invention comprises (a) an outer housing,... |
|
|
Invention
|
Anti-ox40 antagonistic antibodies for the treatment of atopic dermatitis. The present invention r... |
|
|
Invention
|
Benzamide compounds as ror gamma modulators. The present disclosure is directed to compounds of f... |
|
2016
|
Invention
|
Aryl and heteroaryl ether compounds as ror gamma modulators. Provided are compounds of formula (I... |
|
|
Invention
|
Anti-trka antibodies with enhanced inhibitory properties and derivatives thereof.
The present in... |
|
|
Invention
|
Novel carbocyclic compounds as ror gamma modulators. The present disclosure is directed to novel ... |
|
|
Invention
|
Novel compounds as ror gamma modulators. The present disclosure is directed to compounds of formu... |
|
|
Invention
|
Production of t cell retargeting hetero-dimeric immunoglobulins.
The present invention describes... |
|
|
Invention
|
Polymorphs of a pges-1 inhibiting triazolone compound. The present application relates to solid s... |
|
|
Invention
|
Drug delivery device. Disclosed herein is a syringe device comprises (a) an outer housing, (b) a ... |
|
|
Invention
|
Anal device |
|
|
Invention
|
Treatment of respiratory disorders using ror- gamma inhibitors. The present patent application re... |
|
2015
|
Invention
|
Anti-trka antibodies with enhanced inhibitory properties and derivatives thereof for use in treat... |
|
|
Invention
|
Nanoparticulate formulation comprising a mpges-1 inhibitor.
The present invention relates to a n... |
|
|
Invention
|
T cell retargeting hetero-dimeric immunoglobulins.
The present invention describes novel hetero-... |
|
|
Invention
|
Aryl and heteroaryl ether compounds as ror gamma modulators. 3, n, and p are as defined herein, w... |
|
|
Invention
|
Expression constructs and methods for selecting host cells expressing polypeptides.
The inventio... |
